8arm PEG Succinimidyl Glutarate (tripentaerythritol)


PEG products with additional MW may be made to order, please contact us for details


8arm PEG Succinimidyl Glutarate (tripentaerythritol) reagent with superior quality specification of ≥95% Substitution.

JenKem Technology’s 8arm PEG Succinimidyl Glutarate (tripentaerythritol) derivatives can be crosslinked into degradable PEG hydrogels. 8arm PEG Succinimidyl Glutarate (tripentaerythritol) is a cleavable PEG linker. The cleavable ester linker between PEG and NHS ester enables the feature of “degradable” hydrogels. PEG hydrogels have a variety of applications in medical devices and regenerative medicine, and are especially of interest for controlled release of drugs, for 2D and 3D cell culture, and for wound sealing and healing. JenKem Technology’s 8 arm (TP) PEGs are synthesized by ethoxylation of tripentaerythritol. 8ARM(TP)-PEG polymers with tripentaerythritol core have a higher purity as evidenced by MALDI compared with the generic 8ARM-PEG polymers with a hexaglycerin core.8ARM TP CORE ADVANTAGES

The number of ethylene oxide units in the PEG chain may not be equal for all arms. The total molecular weight reported for the JenKem multi-arm PEGs is the sum of the PEG molecular weights of each arm. Multi-arm star PEG products with molecular weights, branching, and functional groups not listed in our online catalog may be available by custom synthesis. Please inquire at tech@jenkemusa.com about pricing and availability.

Bulk PEGs and GMP grade PEGs are made-to-order. Please contact us for bulk pricing.

Click here to download the MSDS


  1. Zhang, Z., et al., Polyphenol nanocomplex modulates lactate metabolic reprogramming and elicits immune responses to enhance cancer therapeutic effect, Drug Resistance Updates, V. 73, 2024.
  2. Yue, W., et al., An injectable in situ hydrogel platform for sustained drug release against Glioblastoma, Journal of Drug Delivery Science and Technology, V. 95, 2024.
  3. Luo, X., et al., Cancer cell membrane proteins-encapsulated nanovaccine enhances cancer immunotherapy and prevention by provoking antigen-specific cellular immunity via the dendritic cell-targeted delivery, Chemical Engineering Journal, 2024.
  4. Huo, Y., et al., Functional Trachea Reconstruction Using 3D‐Bioprinted Native‐Like Tissue Architecture Based on Designable Tissue‐Specific Bioinks. Advanced Science. 2022.
  5. Sang, W., et al., A Triple‐Kill Strategy for Tumor Eradication Reinforced by Metal‐Phenolic Network Nanopumps. Advanced Functional Materials. 2022.
  6. Tong, X. et al, Engineering interpenetrating network hydrogels as biomimetic cell niche with independently tunable biochemical and mechanical properties, Biomaterials, 2014, 35, p: 1807-1815.

Founded in 2001 by experts in PEG synthesis and PEGylation, JenKem Technology specializes exclusively in the development and manufacturing of high quality polyethylene glycol (PEG) products and derivatives, and related custom synthesis and PEGylation services. JenKem Technology is ISO 9001 and ISO 13485 certified, and adheres to ICH Q7A guidelines for GMP manufacture. The production of JenKem® PEGs is back-integrated to in-house polymerization from ethylene oxide, enabling facile traceability for regulated customers. JenKem Technology caters to the PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through large commercial scale.


Go to Top